Gout

      RT @RichardPAConway: Dr England presents on multimorbidity in RA, PsA, gout, and OA within RISE registry. Highly prevale

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr England presents on multimorbidity in RA, PsA, gout, and OA within RISE registry. Highly prevalent in all 4 but most pronounced in gout and RA. Critical to recognise and manage. @rheumnow #ACR20 Abstr#1466 https://t.co/XtwIfJnVXV
      RT @DrMiniDey: Study incl 1243 #SLE patients finds excess risk of #cardiovascular events is underestimated by CVD predic

      Mrinalini Dey DrMiniDey

      4 years 11 months ago
      Study incl 1243 #SLE patients finds excess risk of #cardiovascular events is underestimated by CVD prediction tools- the underestimation may be increased in those with more severe disease activity. Abs#1286 #ACR20 @RheumNow https://t.co/6FZvxE02CF
      Pegloticase in Severe Refractory Gout: Dr. Olga Petryna
      4 years 11 months ago

      Dr. Petryna reviews several pegloticase-related abstracts presented at the ACR 2020 annual meeting, including abstracts #0683 and #0677. 

      Improving Response to Pegloticase: Dr. Nicola Dalbeth
      4 years 11 months ago

      Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.

      GCAN Report: Gout, Urate and the repositioning of innate immunity: Dr. Michael Pillinger
      4 years 11 months ago

      NYU's Dr. Michael Pillinger promises deeper looks at ACR 2020 activity regarding gout, but starts out reporting data from GCAN.

      RT @MeralElRamahiMD: So excited to check out RheumNow’s ACR Mid-Meeting Recap live right now with Dr. Jack Cush (@rheu

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 11 months ago
      So excited to check out RheumNow’s ACR Mid-Meeting Recap live right now with Dr. Jack Cush (@rheumnow), Dr. Arthur Kavanaugh, Dr. Michale Pillinger, and Dr. Bella Mehta! #ACR20
      Crystal Arthritis and Gout Highlights at ACR: Dr. Nicola Dalbeth
      Gout specialist Dr. Nicola Dalbeth from Aukland, New

      Dr. John Cush RheumNow

      4 years 11 months ago
      Crystal Arthritis and Gout Highlights at ACR: Dr. Nicola Dalbeth Gout specialist Dr. Nicola Dalbeth from Aukland, New Zealand provides a preview perspective on crystal arthritis and gout studies and sessions at #ACR20. https://t.co/QfVSpeVXlf https://t.co/cBwKF5P5eb
      RT @MeralElRamahiMD: Reducing Immunogenicity of Pegloticase (RECIPE) w/ concomitant use of MMF in pts w/ refractory gout

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 11 months ago
      Reducing Immunogenicity of Pegloticase (RECIPE) w/ concomitant use of MMF in pts w/ refractory gout is a phase II double blind RCT that shows sustained serum urate lowering effect in addition to decrease in monthly rate of flares. #ACRbest #Abst0952 @RheumNow Practice changing? https://t.co/Z7GwCXZftE
      RT @drpnash: AR882, a Potent and Selective Uricosuric Agent, Significantly Reduced Serum Urate Levels Following Multiple

      Peter Nash drpnash

      4 years 11 months ago
      AR882, a Potent and Selective Uricosuric Agent, Significantly Reduced Serum Urate Levels Following Multiple Ascending Once-Daily Doses in Healthy Subject Volunteers https://t.co/fRB2zuKl5J #gout #uricosuric a novel uricosuric agent
      RT @MeralElRamahiMD: Based on RECIPE, how many of you will use MMF concomitantly with start of pegloticase in treating r

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 11 months ago
      Based on RECIPE, how many of you will use MMF concomitantly with start of pegloticase in treating refractory gout patients? #ACR20 @RheumNow
      RT @RichardPAConway: Dr Khanna presents RECIPE RCT of MMF to reduce immunogenicity of pegloticase. Sustained urate respo

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr Khanna presents RECIPE RCT of MMF to reduce immunogenicity of pegloticase. Sustained urate response ≤6mg/dL at 24 weeks 68% with MMF compared to 30% in placebo. @rheumnow #ACR20 Abstr#952 #ACRbest https://t.co/64nN5AqK3W
      RT @RichardPAConway: Dr Merriman presents on role of diet in gout. It is minor, especially compared to urate lowering th

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr Merriman presents on role of diet in gout. It is minor, especially compared to urate lowering therapy. Average attributable fraction approximately 10-fold greater for ULT than following healthy-eating guidelines. @rheumnow #ACR20 Abstr#951 https://t.co/1tftswOEJq
      RT @RichardPAConway: Dr Cai presents risk of CVD in gout in study 450,000 patients. Gout was independently associated wi

      Richard Conway RichardPAConway

      4 years 11 months ago
      Dr Cai presents risk of CVD in gout in study 450,000 patients. Gout was independently associated with an increased risk of CVD events HR = 1.24 for women; 1.21 for men. @rheumnow #ACR20 Abstr#950 #ACRbest https://t.co/089aKtN5a7
      gout.MTP_.jpg
      Decreasing immunogenicity, improving efficacy of pegloticase in gout
      4 years 11 months ago
      At #ACR20 three different medications are reviewed in different studies to decrease the immunogenicity of pegloticase – Methotrexate, Azathioprine and Mycophenolate Mofetil.  
      RT @BolekBerqui: Evidence-Based Guidance for Optimizing Gout #ACR20 Reminding us of cardioprotective effect of anti-infl

      Jilaine Bolek Berquist BolekBerqui

      4 years 11 months ago
      Evidence-Based Guidance for Optimizing Gout #ACR20 Reminding us of cardioprotective effect of anti-inflammatory gout management with colchicine. https://t.co/TmsrRd2vFD

      Catch up on Conference Podcasts

      ×